2 results
Approved WMOPending
The primary objective of this study is to assess whether tacrolimus is effective for the treatment of morphea.
Approved WMOCompleted
Compare Progression Free Survival (PFS) for brivanib versus placebo in subjects with advanced solid tumors with FGF-2 over-expression and who have obtained stable disease after 12 weeks of treatment with brivanib separately for each tumor.